Narayana Hrudayalaya Ltd.
NH · General/Diversified · NSE
₹1,784
Current Market Price
Fair Value (DCF)
₹931
Margin of Safety
-47.8%
Updated 1d ago
YieldIQ Score
47/100
Piotroski F-Score
5/9
Economic Moat
Moderate
Confidence
27%
ROE
21.8%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.36 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
17.8%
Return on capital employed
EV / EBITDA
25.8×
Enterprise multiple
Debt / EBITDA
1.6×
Leverage vs earnings
Interest Coverage
7.4×
EBIT covers interest
Current Ratio
2.14×
Short-term liquidity
Asset Turnover
0.86×
Revenue per ₹ of assets
Revenue CAGR (3Y)
13.7%
3-year revenue growth
Revenue CAGR (5Y)
20.9%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,783.9
Bear case
₹523.87
MoS -240.5%
Base case
₹931.34
MoS -91.5%
Bull case
₹1,276.42
MoS -39.8%
Ratio Trends
NH · last 8 annual periods
ROE
21.8%
ROCE
22.5%
Operating Margin
—
Debt / Equity
0.67×
PE
25.9×
EV / EBITDA
15.2×
Historical Financials
NH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2582 Cr | ₹3701 Cr | ₹4525 Cr | ₹5018 Cr | ₹5483 Cr | +20.7% |
| EBITDA | — | ₹679 Cr | ₹1031 Cr | ₹1223 Cr | ₹1362 Cr | +19.0% |
| EBIT | ₹19.9 Cr | ₹496 Cr | ₹821 Cr | ₹985 Cr | — | +165.2% |
| PAT | ₹-14.3 Cr | ₹342 Cr | ₹607 Cr | ₹790 Cr | ₹790 Cr | — |
| EPS (diluted) | ₹-0.70 | ₹16.84 | ₹29.85 | ₹38.86 | — | — |
| CFO | ₹309 Cr | ₹485 Cr | ₹1085 Cr | ₹1067 Cr | ₹986 Cr | +33.6% |
| CapEx | — | — | — | — | ₹-1082 Cr | — |
| FCF | — | — | — | — | ₹-96.2 Cr | — |
| Total Assets | — | ₹3131 Cr | ₹4162 Cr | ₹5625 Cr | ₹7265 Cr | +23.4% |
| Total Debt | — | — | ₹136 Cr | ₹249 Cr | ₹2428 Cr | +105.6% |
| Shareholders' Equity | — | — | ₹2131 Cr | ₹2884 Cr | ₹3628 Cr | +14.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| ASTERDM Aster DM Healthcare Limited | -74.5% | 48 | Data Limited | 147.3% | — |
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
| KIMS Krishna Institute of Medical Sciences Limited | -57.2% | 50 | Data Limited | 15.9% | — |
| FORTIS Fortis Healthcare Limited | -47.8% | 58 | Above Fair Value | 8.4% | — |
| MAXHEALTH Max Healthcare Institute Limited | -48.7% | 50 | Above Fair Value | 11.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
6 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹12.00/sh
Last payout
2025-08-01
₹4.50
Peak payout
₹4.50
Trailing yield
0.25%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of NH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NH →
Compare
Head-to-head with peers
Compare NH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.